Home
Conditions
Dendritic Cell Sarcoma, Interdigitating

Clinical trial condition

Dendritic Cell Sarcoma, Interdigitating

Explore clinical trials studying Dendritic Cell Sarcoma, Interdigitating. Study availability and eligibility vary by location and protocol.

236 public trials 31 recruiting studies

Refine in advanced search Browse all conditions

Dendritic Cell Sarcoma, Interdigitating trial results

Recruiting

Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL

NCT07057765

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +6 more
Locations: Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Ain Shams University Cairo, Cairo Governorate, Egypt

View Trial Details

Recruiting

Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy

NCT05377307

Conditions: Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Grade 3A, +16 more
Locations: Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung, Taiwan

National Taiwan University Hospital Taipei, Taiwan

Taipei Veterans General Hospital Taipei, Taiwan

Chi Mei Medical Center Tainan, Taiwan

View Trial Details

Recruiting

Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes

NCT06891157

Conditions: Chidamide, DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +8 more
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Recruiting

Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL

NCT06151080

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Follicular Lymphoma, +12 more
Locations: Bing Xu Xiamen, Fujian, China

View Trial Details

Recruiting

AZA Combined With RCHOP in P53-mutated DLBCL.

NCT06158399

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +6 more
Locations: Bing Xu Xiamen, Fujian, China

View Trial Details

Recruiting

Real-World Study of DLBCL With Different Genetic Subtypes

NCT06026488

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +9 more
Locations: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL

NCT05641428

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +6 more
Locations: NL-Amsterdam-AMC Amsterdam, Netherlands

NL-Groningen-UMCG Groningen, Netherlands

NL-Leiden-LUMC Leiden, Netherlands

NL-Maastricht-MUMC Maastricht, Netherlands

View Trial Details

Recruiting

Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study

NCT06534762

Conditions: Breast Diseases, Breast Neoplasms, Carcinoma, +45 more
Locations: Zhejiang Provincial People's Hospital Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict)

NCT06526065

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
Locations: Universitätsmedizin Göttingen Göttingen, Lower Saxony, Germany

View Trial Details

Recruiting

Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL

NCT06287398

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, DLBCL, Nos Genetic Subtypes, Dendritic Cell Sarcoma, Interdigitating, +21 more
Locations: Australasian Leukemia and Lymphoma Group Melbourne, Victoria, Australia

View Trial Details

Dendritic Cell Sarcoma, Interdigitating

Dendritic Cell Sarcoma, Interdigitating trial results

Related conditions